why is compound tirzepatide banned What the latest update on the Compounded ban Compounded Tirzepatide: Legal & Safe

Your initial consultation with Barbara Sand, PA-C, or one of our Registered Nurses will confirm whether the program is right for you

IPL: Which One Is Better for Your Skin Concern

Bruising at injection sites occurs in approximately 10-15% of patients starting GLP-1 therapy, particularly during the first month of treatment

Market Share (2022): Trulicity led with approximately 44% of GLP-1 sales, while Victoza held around 37%, and Ozempic accounted for 12% internationally

In one case report, early antenatal exposure to GLP-1 therapy was associated with neonatal macrosomia, shoulder dystocia and neonatal hypoglycemia